GOODWILL AND INTANGIBLE ASSETS (Details Textual) (USD $)	0 Months Ended		1 Months Ended	3 Months Ended		9 Months Ended		1 Months Ended	9 Months Ended	1 Months Ended	9 Months Ended
	Mar. 06, 2014	Jan. 02, 2014	Dec. 31, 2013	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Jul. 31, 2014 Lithobid Purchase Agreement [Member]	Sep. 30, 2014 Lithobid Purchase Agreement [Member]	Aug. 31, 2014 Vancocin Purchase Agreement [Member]	Sep. 30, 2014 Vancocin Purchase Agreement [Member]	Sep. 30, 2014 Acquired ANDA Intangible Asset [Member]	Dec. 31, 2013 Acquired ANDA Intangible Asset [Member]
GOODWILL AND INTANGIBLE ASSETS
Amortization of Intangible Assets				$ 1,000,000	$ 200,000	$ 2,200,000	$ 300,000
Finite-Lived Intangible Assets, Gross			11,060,000	45,999,000		45,999,000			12,000,000		10,500,000	12,577,000	60,000
Goodwill, Acquired During Period							1,800,000
Intangible Asset Purchase Agreement Quantity Acquired			31
Intangible Asset Purchase Type Of Products			generic drug products
Intangible Asset Purchase Agreement, Amount			12,500,000
Intangible Asset Purchase Agreement Payment	4,000,000	8,500,000
Intangible Asset Purchase Agreement Number Of Immediate Release Products			20
Finite-Lived Intangible Asset, Useful Life								10 years	10 years	10 years	10 years	10 years
Payments to Acquire Intangible Assets									11,000,000	11,000,000	11,000,000
Payment To Acquire Intangible Assets If Contingency Occurs									$ 1,000,000